Overview
Koji Yoshino practices in Tokyo, Japan. Mr. Yoshino is rated as an Elite expert by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Angiosarcoma, Extramammary Paget Disease, Melanoma, and Angiosarcoma of the Scalp.
His clinical research consists of co-authoring 87 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Angiosarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AngiosarcomaMr. Yoshino isElite. Learn about Angiosarcoma.
- Extramammary Paget DiseaseMr. Yoshino isElite. Learn about Extramammary Paget Disease.
- Advanced
- Adult Soft Tissue SarcomaMr. Yoshino isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Angiosarcoma of the ScalpMr. Yoshino isAdvanced. Learn about Angiosarcoma of the Scalp.
- MelanomaMr. Yoshino isAdvanced. Learn about Melanoma.
- Experienced
- Basal Cell Skin CancerMr. Yoshino isExperienced. Learn about Basal Cell Skin Cancer.
- Bronchiolitis ObliteransMr. Yoshino isExperienced. Learn about Bronchiolitis Obliterans.
- Clear Cell SarcomaMr. Yoshino isExperienced. Learn about Clear Cell Sarcoma.
- DacryoadenitisMr. Yoshino isExperienced. Learn about Dacryoadenitis.
- HypothyroidismMr. Yoshino isExperienced. Learn about Hypothyroidism.
- Lymphofollicular HyperplasiaMr. Yoshino isExperienced. Learn about Lymphofollicular Hyperplasia.